Pertagen Dosage/Direction for Use

Posology: A single 0.5 mL dose of Pertagen is recommended.
Pertagen may be given in individuals aged 3 years and onwards requiring protection against pertussis only as booster, catch-up or maternal immunization in accordance with national, WHO, US or EU official recommendations or medical practices, including: Pregnant adolescents and women in the second or third trimester to prevent pertussis in mothers and in infants in early infancy (see Indications/Uses and Use in Pregnancy & Lactation).
Multiparous women with closely spaced pregnancies to avoid "over-vaccination" and hypersensitivity reactions due to repeated injections of tetanus-diphtheria-acellular pertussis (Tdap) containing vaccines (see Indications/Uses and Use in Pregnancy & Lactation).
Household contacts of vulnerable populations and childcare providers.
Healthcare workers to prevent nosocomial transmission to vulnerable patients.
For catch up immunization (if previous pertussis booster dose missed).
During pertussis outbreaks.
Pertagen can be used as an alternative to other acellular pertussis-containing vaccines for pertussis booster immunization in persons with known hypersensitivity to tetanus (Arthus-type hypersensitivity reaction) or diphtheria vaccines and in persons who have received multiple and frequent tetanus or diphtheria vaccine doses.
Method of administration: Pertagen should be administered by intramuscular injection, preferably in the deltoid region.
Shake well before use. Do not use if resuspension does not occur after vigorous shaking or foreign particles or discoloration are observed. Administer the total volume of 0.5 mL intramuscularly (IM) (see Precautions).